True Wealth Design, LLC Summit Therapeutics Inc. Transaction History
True Wealth Design, LLC
- $284 Billion
- Q2 2025
A detailed history of True Wealth Design, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 18 shares of SMMT stock, worth $515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18
Previous 4
350.0%
Holding current value
$515
Previous $78,000
392.31%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SMMT
# of Institutions
248Shares Held
84.1MCall Options Held
1.76MPut Options Held
2.43M-
Baker Bros. Advisors LP New York, NY24.4MShares$700 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.67MShares$249 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$226 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$188 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$139 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.77B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...